Table 2.
Number of IL-17+ cells from different sources isolated postischemic rats
| Euthymic Sham | Euthymic I/R | Athymic Sham | Athymic I/R | |
|---|---|---|---|---|
| Total IL-17 | 223 ± 747 | 8,279 ± 1,766 | 1,011 ± 689 | 6,514 ± 1,696 |
| CD4+IL-17+ | 988 ± 77 | 3,980 ± 1,006 | 606 ± 59 | 2,154 ± 586 |
| CD8+IL-17+ | 1,668 ± 981 | 3,138 ± 1,583 | 1,166 ± 1,092 | 3,808 ± 2,573 |
| CD161+IL-17+ | 249 ± 21 | 2,057 ± 556 | 173 ± 51 | 4,493 ± 1,206* |
| CD4+CD161+ | 80 ± 63 | 1,492 ± 389 | 117 ± 28 | 3,752 ± 958* |
| CD4+CD161− | 205 ± 193 | 2,252 ± 451 | 181 ± 69 | 807 ± 147* |
Data are means ± SE; n = 5–6 animals/group. I/R, ischemia-reperfusion. The table depicts the number of IL-17+ cells/g of kidney from different cell subtypes isolated from 35 days post-I/R.
*
P < 0.05, injury vs. sham group using ANOVA and Student-Neuman-Keuls post hoc test.